These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 32232184)

  • 41. Identification and validation of immune-related biomarkers and potential regulators and therapeutic targets for diabetic kidney disease.
    Chen S; Li B; Chen L; Jiang H
    BMC Med Genomics; 2023 May; 16(1):90. PubMed ID: 37127580
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urine synaptopodin excretion is an important marker of glomerular disease progression.
    Kwon SK; Kim SJ; Kim HY
    Korean J Intern Med; 2016 Sep; 31(5):938-43. PubMed ID: 27604800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients.
    Milas O; Gadalean F; Vlad A; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Popescu R; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Secara A; Simulescu A; Stefan M; Patruica M; Petrica F; Vlad D; Petrica L
    J Diabetes Complications; 2020 Feb; 34(2):107479. PubMed ID: 31806428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Signaling Pathways of Podocyte Injury in Diabetic Kidney Disease and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors.
    Chen X; Wang J; Lin Y; Liu Y; Zhou T
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497173
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Presence and Location of Podocytes in Glomeruli as Affected by Diabetes Mellitus.
    Maraszek KE; Santo BA; Yacoub R; Tomaszewski JE; Mohammad I; Worral AM; Sarder P
    Proc SPIE Int Soc Opt Eng; 2020 Feb; 11320():. PubMed ID: 32362706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
    Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Research progress on multiple cell death pathways of podocytes in diabetic kidney disease.
    Yang C; Zhang Z; Liu J; Chen P; Li J; Shu H; Chu Y; Li L
    Mol Med; 2023 Oct; 29(1):135. PubMed ID: 37828444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement.
    Wang Q; Tian X; Wang Y; Wang Y; Li J; Zhao T; Li P
    J Diabetes Res; 2020; 2020():6897390. PubMed ID: 31998809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modified Hu-lu-ba-wan protects diabetic glomerular podocytes via promoting PKM2-mediated mitochondrial dynamic homeostasis.
    Gong M; Guo Y; Dong H; Wu F; He Q; Gong J; Lu F
    Phytomedicine; 2024 Jan; 123():155247. PubMed ID: 38128393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease.
    Guo J; Lei M; Cheng F; Liu Y; Zhou M; Zheng W; Zhou Y; Gong R; Liu Z
    Cell Death Dis; 2020 Jun; 11(6):413. PubMed ID: 32487989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease
    Wang MZ; Wang J; Cao DW; Tu Y; Liu BH; Yuan CC; Li H; Fang QJ; Chen JX; Fu Y; Wan BY; Wan ZY; Wan YG; Wu GW
    Front Pharmacol; 2022; 13():790937. PubMed ID: 35370636
    [No Abstract]   [Full Text] [Related]  

  • 53. SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease.
    Yang Q; Xie W; Wang X; Luo J; Zhou Y; Cao H; Sun Q; Jiang L; Yang J
    Front Pharmacol; 2021; 12():707006. PubMed ID: 36338294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tyro3 is a podocyte protective factor in glomerular disease.
    Zhong F; Chen Z; Zhang L; Xie Y; Nair V; Ju W; Kretzler M; Nelson RG; Li Z; Chen H; Wang Y; Zhang A; Lee K; Liu Z; He JC
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes.
    Casalena GA; Yu L; Gil R; Rodriguez S; Sosa S; Janssen W; Azeloglu EU; Leventhal JS; Daehn IS
    Cell Commun Signal; 2020 Jul; 18(1):105. PubMed ID: 32641054
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.
    Horne SJ; Vasquez JM; Guo Y; Ly V; Piret SE; Leonardo AR; Ling J; Revelo MP; Bogenhagen D; Yang VW; He JC; Mallipattu SK
    Diabetes; 2018 Nov; 67(11):2420-2433. PubMed ID: 30115650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.
    Wang H; Feng Z; Xie J; Wen F; Jv M; Liang T; Li J; Wang Y; Zuo Y; Li S; Li R; Li Z; Zhang B; Liang X; Liu S; Shi W; Wang W
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1096-F1107. PubMed ID: 29361670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IQGAP1 mediates podocyte injury in diabetic kidney disease by regulating nephrin endocytosis.
    Liu Y; Su H; Ma C; Ji D; Zheng X; Wang P; Zheng S; Wang L; Wang Z; Xu D
    Cell Signal; 2019 Jul; 59():13-23. PubMed ID: 30857827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diabetic kidney disease in pediatric patients: A current review.
    Muntean C; Starcea IM; Banescu C
    World J Diabetes; 2022 Aug; 13(8):587-599. PubMed ID: 36159227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.